Is there any benefit in maintaining statin or aspirin therapy in patients >75 years old with stable, multivessel ischemic heart disease in light of challenges encountered with polypharmacy?  

This is a great geriatric cardiology question because it acknowledges that guidelines may not apply in an older patient with multiple medical problems and a complex medication regimen. The question further implies that treatment should be individualized and patient-centered. I agree with the questio...

I totally agree with your very thoughtful answer. However, a lot of times in my practice as a geriatric cardiologist, solely taking care of geriatric Medicare patients whom a lot of them have ischemic heart disease along with other comorbidities, I realize that there are so many other unnecessary me...